Seville to Host the International Congress on Neurodegenerative Diseases (ICND), Organized by the Reina Sofía Foundation and CIEN

• H. M. Queen Sofía will preside over the Congress opening ceremony on Monday, 21 September
• The event, taking place from 21 to 23 September, will bring together leading national and international researchers and experts
• The scientific programme will focus on the latest advances in biomarkers applied to neurodegenerative diseases

On Monday, 21 September, coinciding with World Alzheimer’s Day, the International Congress on Neurodegenerative Diseases (ICND) will get underway in Seville, bringing together leading international researchers and experts. The Congress will be presided over by H. M. Queen Sofía, once again demonstrating her commitment to and support for research and for people affected by neurodegenerative diseases.

This annual meeting, jointly organized by the Reina Sofía Foundation and the Center for Research on Neurological Diseases (CIEN), with the collaboration of the Institute of Biomedicine of Seville (IBiS), will provide a platform for sharing the latest advances in research and promoting knowledge exchange among researchers from different fields.

In this context, the Congress reflects the Reina Sofía Foundation’s strong commitment to research into Alzheimer’s disease and other neurodegenerative diseases, as well as to improving the quality of life of those affected—one of the key strategic priorities of its social work.

Leading international researchers

This commitment to research is also reflected in the scientific programme of the 13th edition of the Congress, which includes eight thematic sessions covering some of the main areas of research into neurodegenerative diseases, including core biomarkers, inflammation and glial markers, multimodal approaches and artificial intelligence, genetics, brain plasticity and resilience, as well as other dementias and patient populations.

To address these advances, the Congress will feature internationally renowned speakers, including Bill Jagust, from the University of California, Berkeley; Michael Heneka, from the University of Luxembourg; Seth Grant, from the University of Edinburgh; Emrah Düzel, from DZNE; Charlotte Teunissen, from Amsterdam UMC; Tharick Pascoal, from the University of Pittsburgh; and Jonathan Schott, from the UCL Institute of Neurology, among others.

The strength of the scientific programme is also reflected in the growing interest in participating and sharing new research findings. This year’s edition has reached a record number of scientific contributions, with nearly 60 posters selected, providing an opportunity to showcase emerging research and foster knowledge exchange between early-career researchers and international experts. In addition, attendance is expected to be high, with more than 200 participants anticipated on the first day of the Congress.

The scientific programme will be complemented by a **health and social care session**, aimed at promoting dialogue among researchers, healthcare professionals, patient and family associations, and institutional representatives. This session will address some of the key challenges in dementia care and highlight the importance of collaboration between science, healthcare systems and society.

ICND receives MedTech Europe ethical conference certification

The growth of the Congress is also reflected in the support it has received from the business sector. For the first time, this 13th edition has obtained MedTech Europe ethical conference certification